Use of the cholesterol-lowering drug fenofibrate had a modest but statistically significant association with reduced risk of vision-threatening diabetic retinopathy (VTDR), according to results of a ... Medscape: Fenofibrate Works as Well in Women With Diabetes as in Men A new analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial has shown that the lipid-lowering therapy works just as well in women as in men. These results are key, say ...

Understanding the Context

kidney cross section Researchers assessed the incidence and potential risk factors for the development of fenofibrate-associated nephrotoxicity in patients with gout. Fenofibrate-associated ... News Medical: First-ever clinical trials evaluate fenofibrate as treatment for HPV-related cancers A team from University Hospitals Seidman Cancer Center is launching the nation's first-ever clinical trials evaluating the cholesterol drug fenofibrate (Triglide, Fibricor, Lipofen) as an ... Healio: Fenofibrate may lower heart failure hospitalization, CV mortality in type 2 diabetes Fenofibrate may lower heart failure hospitalization, CV mortality in type 2 diabetes What is fenofibrate used for?

Key Insights

Fenofibrate is commonly used to lower bad cholesterol (LDL-C) and increase good cholesterol (HDL-C) in people with high cholesterol or mixed dyslipidemia (elevated ... Please provide your email address to receive an email when new articles are posted on . Adults taking oral fenofibrate had a 27% reduction in diabetic eye disease progression over 4 years. Fenofibrate ... Nature: Fenofibrate inhibits adipocyte hypertrophy and insulin resistance by activating adipose PPARα in high fat diet-induced obese mice Peroxisome proliferator-activated receptor α (PPARα) activation in rodents is thought to improve insulin sensitivity by decreasing ectopic lipids in non-adipose tissues.

Final Thoughts

Fenofibrate, a lipid-modifying ... Fenofibrate inhibits adipocyte hypertrophy and insulin resistance by activating adipose PPARα in high fat diet-induced obese mice NEW ORLEANS, – Results from a new study showed that coadministration of ZETIA® (ezetimibe) and fenofibrate significantly reduced LDL ("bad") cholesterol (LDL-C), non-high density ... Children with hypertriglyceridemia treated with fenofibrate had lower levels of triglycerides, low-density lipoprotein cholesterol, and total cholesterol than those treated with omega-3 fatty acids. Fenofibrate Found Safe in Diabetes With Renal Impairment Long-term daily use of fenofibrate is beneficial for patients with type 2 diabetes and moderate renal impairment and is not associated with an ... The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study was a randomized, double-blind, placebo-controlled trial conducted in Australia, New Zealand, and Finland that was designed to ... EurekAlert!: Study shows fenofibrate reduces need for laser treatment for diabetic retinopathy Treatment with fenofibrate in individuals with type 2 diabetes mellitus reduces the need for laser treatment for diabetic retinopathy (DR), conclude authors of an Article published early Online and in ...

ORLANDO, Fla. — The old, generic cholesterol drug fenofibrate has shown potential for slowing the progression of diabetic retinopathy in people with early retinal changes, with the potential to reduce ... ORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. Fenofibrate also reduced the chance of any progression of ...